(Q45730628)

English

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression

scientific article published on 25 September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Fernando Dronda

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Santiago Moreno

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Ana Moreno

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

José L Casado

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

María J Pérez-Elías

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Antonio Antela

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

25 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1005-1009

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Lymphoid tissue viral burden and duration of viral suppression in plasma

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment.

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Immune restoration with antiretroviral therapies: implications for clinical management

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

1 reference

https://api.crossref.org/works/10.1086%2F342695

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45730628&oldid=2079012505"